Overview

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Status:
Terminated
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
To assess safety, efficacy and explorative objectives of gefitinib in combination with chemoradiation in resectable gastric cancer
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Fluorouracil
Gefitinib
Leucovorin